4021

Nissan Chemical Corporation

日産化学株式会社
Basic Materials · Chemicals
Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; HARDBEADS, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. It also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, the company provides pharmaceutical products, such as LIVALO, a antihypercholesterolemic agent; LANDEL and FINTE, a long-acting calcium channel blocker; and APIs and intermediaries, as well as develops NTC-801, a pharmacological therapeutic agent for treatment of arrhythmia. Further, it develops healthcare, information and communication, and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.
← Companies
Price
¥7,509
Market Cap
¥1.0T
Ent. Value
¥1.0T
Net Debt
−¥4.0B
Shares Out.
136.4M
P / E
24.0×
EV / EBIT
18.1×
P / Book
4.39×
P / NCAV
8.85×
Div. Yield
2.32%
Financials
Metric FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥251.4B ¥226.7B ¥228.1B ¥208.0B
Cost of Sales ¥134.8B ¥121.9B ¥121.3B ¥106.9B
Gross Profit ¥116.5B ¥104.8B ¥106.8B ¥101.1B
SG&A ¥59.7B ¥56.6B ¥54.5B ¥50.1B
Operating Income ¥56.8B ¥48.2B ¥52.3B ¥51.0B
Non-Operating Income ¥4.3B ¥5.3B ¥5.0B ¥3.8B
Dividend Income ¥1.7B ¥1.6B ¥1.3B ¥768M
Interest Income ¥217M ¥161M ¥203M ¥49M
Non-Operating Expenses ¥3.1B ¥1.9B ¥1.5B ¥1.1B
Interest Expense ¥654M ¥526M ¥252M ¥73M
Ordinary Income ¥58.0B ¥51.6B ¥55.8B ¥53.7B
Pre-tax Income ¥59.5B ¥51.8B ¥56.6B ¥54.2B
Income Taxes ¥16.5B ¥13.6B ¥15.2B ¥15.0B
Current Tax ¥17.3B ¥12.8B ¥14.6B ¥14.7B
Deferred Tax ¥-828M ¥730M ¥633M ¥312M
Net Income (owners) ¥43.0B ¥38.0B ¥41.1B ¥38.8B
Minority Interest ¥-92M ¥172M ¥329M ¥357M
Comprehensive Income ¥39.4B ¥42.5B ¥41.7B ¥36.5B
EBITDA ¥71.2B ¥62.0B ¥63.3B ¥61.2B
Goodwill Amort. (J-GAAP) ¥53M ¥101M ¥101M ¥103M
EPS ¥313.26 ¥272.82 ¥291.36 ¥271.88
Shares Outstanding 136.4M 138.8M 140.4M 141.8M
Shares Issued (total) 136.8M 138.8M 141.3M 143.0M
Treasury Shares 0.4M 0.0M 0.9M 1.2M